Lymphatic Filariasis

Tropical Infectious Diseases

Volumn , Issue , 2011, Pages 729-734

  Nutman, Thomas B ^a,b   Kazura, James W ^c  

^a Helminth Immunology Section and Head   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84867167843     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7020-3935-5.00104-X     Document Type: Chapter

References (132)

1. Mathers CD, Ezzati M, Lopez AD Measuring the burden of neglected tropical diseases: the global burden of disease framework. PLoS Negl Trop Dis 2007, 1:e114.
2. Haddix AC, Kestler A Lymphatic filariasis: economic aspects of the disease and programmes for its elimination. Trans R Soc Trop Med Hyg 2000, 94:592.
3. Ottesen EA Lymphatic filariasis: treatment, control and elimination. Adv Parasitol 2006, 61:395.
4. Routh HB, Bhowmik KR History of elephantiasis. Int J Dermatol 1993, 32:913.
5. Rajan TV Lymphatic Filariasis: A Historical Perspective 2000, Imperial College Press, London.
6. Demarquay J-N Helminthologie. Gaz Med Paris 1863, 18:665.
7. Wucherer OEH Noticia preliminar sobrevermes de uma especie ainda nao descripta, encontrados na urina de donentes de hematuria intertropical no Brazil. Gaz Med Bahia 1868, 3:97.
8. Lewis TR On a Hematozoan Inhabiting Human Blood, Its Relation to Chyluria and Other Diseases 1872, Government of India.
9. Manson P On filarial periodicity. Br Med J 1899, 2:644.
10. Manson P Further Observations on Filaria Sanguinis Hominis. China Imperial Maritime Customs 1877.
11. Cobbold TS Discovery of the adult representative of a microscopic Filariae. Lancet 1877, 2:70.
12. Bourne AG A note on Filaria Sanguinis Hominis (with description of a male specimen). Br Med J 1888, 1:1050.
13. Bancroft TL On the metamorphosis of the young form of Filaria bancrofti Cobbold (Filaria sanguinis hominis Lewis; Filaria nocturna Manson) in the body of Culex ciliaris, the house mosquito of Australia. J Trop Med 1899, 2:91.
14. Low GC A recent observation on Filaria nocturna in Culex: probable mode of infection of man. Br Med J 1900, 1:1456.
15. Buckley JJ On Brugia gen. nov. for Wuchereria spp. of the inverted question markmalayl' group, i.e., W. malayi (Brug, 1927), W. pahangi Buckley and Edeson, 1956, and W. patei Buckley, Nelson and Heisch, 1958. Ann Trop Med Parasitol 1960, 54:75.
16. O'Connor FW Filarial periodicity with observations and on the mechanisms of migration of the microfilariae and from parent worm to the blood stream. P R J Public Health Trop Med 1931, 6:263.
17. Kozek WJ, Marroquin HF Intracytoplasmic bacteria in Onchocerca volvulus. Am J Trop Med Hyg 1977, 26:663.
18. McLaren DJ, Worms MJ, Laurence BR, et al. Micro-organisms in filarial larvae (Nematoda). Trans R Soc Trop Med Hyg 1975, 69:509.
19. Sironi M, Bandi C, Sacchi L, et al. Molecular evidence for a close relative of the arthropod endosymbiont Wolbachia in a filarial worm. Mol Biochem Parasitol 1995, 74:223.
20. Taylor MJ, Hoerauf A Wolbachia bacteria of filarial nematodes. Parasitol Today 1999, 15:437.
21. Hise AG, Gillette-Ferguson I, Pearlman E The role of endosymbiotic Wolbachia bacteria in filarial disease. Cell Microbiol 2004, 6:97.
22. Rajan TV Relationship of anti-microbial activity of tetracyclines to their ability to block the L3 to L4 molt of the human filarial parasite Brugia malayi. Am J Trop Med Hyg 2004, 71:24.
23. Hoerauf A, Mand S, Fischer K, et al. Doxycycline as a novel strategy against bancroftian filariasis-depletion of Wolbachia endosymbionts from Wuchereria bancrofti and stop of microfilaria production. Med Microbiol Immunol (Berl) 2003, 192:211.
24. Supali T, Djuardi Y, Pfarr KM, et al. Doxycycline treatment of Brugia malayi-infected persons reduces microfilaremia and adverse reactions after diethylcarbamazine and albendazole treatment. Clin Infect Dis 2008, 46:1385.
25. Mand S, Pfarr K, Sahoo PK, et al. Macrofilaricidal activity and amelioration of lymphatic pathology in bancroftian filariasis after 3 weeks of doxycycline followed by single-dose diethylcarbamazine. Am J Trop Med Hyg 2009, 81:702.
26. Taylor MJ, Makunde WH, McGarry HF, et al. Macrofilaricidal activity after doxycycline treatment of Wuchereria bancrofti: a double-blind, randomised placebo-controlled trial. Lancet 2005, 365:2116.
27. Global programme to eliminate lymphatic filariasis. Wkly Epidemiol Rec 2008, 83:333.
28. Bockarie M, Kazura J, Alexander N, et al. Transmission dynamics of Wuchereria bancrofti in East Sepik Province, Papua New Guinea. Am J Trop Med Hyg 1996, 54:577.
29. Sasa M Human Filariasis 1976, Baltimore University Press.
30. Kazura JW, Bockarie M, Alexander N, et al. Transmission intensity and its relationship to infection and disease due to Wuchereria bancrofti in Papua New Guinea. J Infect Dis 1997, 176:242.
31. Ottesen EA Infection and disease in lymphatic filariasis - an immunological perspective. Parasitology 1992, 104:571.
32. Dreyer G, Ottesen EA, Galdino E, et al. Renal abnormalities in microfilaremic patients with Bancroftian filariasis. Am J Trop Med Hyg 1992, 46:745.
33. Freedman DO, de Almeida Filho PJ, Besh S, et al. Lymphoscintigraphic analysis of lymphatic abnormalities in symptomatic and asymptomatic human filariasis. J Infect Dis 1994, 170:927.
34. Case T, Leis B, Witte M, et al. Vascular abnormalities in experimental and human lymphatic filariasis. Lymphology 1991, 24:174.
35. Witte MH, Jamal S, Williams WH, et al. Lymphatic abnormalities in human filariasis as depicted by lymphangioscintigraphy. Arch Intern Med 1993, 153:737.
36. Mand S, Marfo-Debrekyei Y, Dittrich M, et al. Animated documentation of the filaria dance sign (FDS) in bancroftian filariasis. Filaria J 2003, 2:3.
37. Noroes J, Addiss D, Santos A, et al. Ultrasonographic evidence of abnormal lymphatic vessels in young men with adult Wuchereria bancrofti infection in the scrotal area. J Urol 1996, 156:409.
38. Noroes J, Addiss D, Amaral F, et al. Occurrence of living adult Wuchereria bancrofti in the scrotal area of men with microfilaraemia. Trans R Soc Trop Med Hyg 1996, 90:55.
39. Dreyer G, Noroes J, Figueredo-Silva J, et al. Pathogenesis of lymphatic disease in bancroftian filariasis: a clinical perspective. Parasitol Today 2000, 16:544.
40. Aguiar-Santos AM, Leal-Cruz M, Netto MJ, et al. Lymph scrotum: an unusual urological presentation of lymphatic filariasis. A case series study. Rev Inst Med Trop Sao Paulo 2009, 51:179.
41. Addiss DG, Brady MA Morbidity management in the Global Programme to Eliminate Lymphatic Filariasis: a review of the scientific literature. Filaria J 2007, 6:2.
42. Dreyer G, Medeiros Z, Netto MJ, et al. Acute attacks in the extremities of persons living in an area endemic for bancroftian filariasis: differentiation of two syndromes. Trans R Soc Trop Med Hyg 1999, 93:413.
43. Informal consultation on evaluation of morbidity in lymphatic filarias 1992, World Health Organization, Geneva, WHO/TDR/FK/92.31.
44. Dreyer G, Mattos D, Noroes J Chyluria. Rev Assoc Med Bras 2007, 53:460.
45. Ottesen EA, Nutman TB Tropical pulmonary eosinophilia. Annu Rev Med 1992, 43:417.
46. Coutinho AD, Rocha A, Medeiros Z, et al. [Tropical filarial pulmonary eosinophilia and its differential diagnosis. Rev Hosp Clin Fac Med Sao Paulo 1998, 53:42.
47. Rom WN, Vijayan VK, Cornelius MJ, et al. Persistent lower respiratory tract inflammation associated with interstitial lung disease in patients with tropical pulmonary eosinophilia following conventional treatment with diethylcarbamazine. Am Rev Respir Dis 1990, 142:1088.
48. Wartman WB Filariasis in American armed servicemen in World War II. Medicine (Baltimore) 1947, 12:181.
49. Partono F, Pribadi PW, Soewarta A Epidemiological and clinical features of Brugia timori in a newly established village. Karakuak, West Flores, Indonesia. Am J Trop Med Hyg 1978, 27:910.
50. Nutman TB Experimental infection of humans with filariae. Rev Infect Dis 1991, 13:1018.
51. Lipner EM, Law MA, Barnett E, et al. Filariasis in travelers presenting to the GeoSentinel Surveillance Network. PLoS Negl Trop Dis 2007, 1:e88.
52. Nelson FK, Greiner DL, Shultz LD, et al. The immunodeficient scid mouse as a model for human lymphatic filariasis. J Exp Med 1991, 173:659.
53. Dreyer G, Addiss D, Roberts J, et al. Progression of lymphatic vessel dilatation in the presence of living adult Wuchereria bancrofti. Trans R Soc Trop Med Hyg 2002, 96:157.
54. Choi EH, Zimmerman PA, Foster CB, et al. Genetic polymorphisms in molecules of innate immunity and susceptibility to infection with Wuchereria bancrofti in South India. Genes Immun 2001, 2:248.
55. Hise AG, Hazlett FE, Bockarie MJ, et al. Polymorphisms of innate immunity genes and susceptibility to lymphatic filariasis. Genes Immun 2003, 4:524.
56. Cuenco KT, Halloran ME, Louis-Charles J, et al. A family study of lymphedema of the leg in a lymphatic filariasis-endemic area. Am J Trop Med Hyg 2004, 70:180.
57. Cuenco KT, Halloran ME, Lammie PJ Assessment of families for excess risk of lymphedema of the leg in a lymphatic filariasis-endemic area. Am J Trop Med Hyg 2004, 70:185.
58. Debrah AY, Mand S, Toliat MR, et al. Plasma vascular endothelial growth factor-A (VEGF-A) and VEGF-A gene polymorphism are associated with hydrocele development in lymphatic filariasis. Am J Trop Med Hyg 2007, 77:601.
59. Cuenco KT, Ottesen EA, Williams SA, et al. Heritable factors play a major role in determining host responses to Wuchereria bancrofti infection in an isolated South Pacific island population. J Infect Dis 2009, 200:1271.
60. Baird JB, Charles JL, Streit TG, et al. Reactivity to bacterial, fungal, and parasite antigens in patients with lymphedema and elephantiasis. Am J Trop Med Hyg 2002, 66:163.
61. McPherson T, Persaud S, Singh S, et al. Interdigital lesions and frequency of acute dermatolymphangioadenitis in lymphoedema in a filariasis-endemic area. Br J Dermatol 2006, 154:933.
62. Shenoy RK Clinical and pathological aspects of filarial lymphedema and its management. Korean J Parasitol 2008, 46:119.
63. Suma TK, Shenoy RK, Kumaraswami V Efficacy and sustainability of a footcare programme in preventing acute attacks of adenolymphangitis in brugian filariasis. Trop Med Int Health 2002, 7:763.
64. Babu S, Bhat SQ, Pavan Kumar N, et al. Filarial lymphedema is characterized by antigen-specific Th1 and Th17 proinflammatory responses and a lack of regulatory T cells. PLoS Negl Trop Dis 2009, 3:e420.
65. Babu S, Blauvelt CP, Kumaraswami V, et al. Chemokine receptors of T cells and of B cells in lymphatic filarial infection: a role for CCR9 in pathogenesis. J Infect Dis 2005, 191:1018.
66. Taylor MJ A new insight into the pathogenesis of filarial disease. Curr Mol Med 2002, 2:299.
67. Debrah AY, Mand S, Specht S, et al. Doxycycline reduces plasma VEGF-C/sVEGFR-3 and improves pathology in lymphatic filariasis. PLoS Pathog 2006, 2:e92.
68. Hise AG, Daehnel K, Gillette-Ferguson I, et al. Innate immune responses to endosymbiotic Wolbachia bacteria in Brugia malayi and Onchocerca volvulus are dependent on TLR2, TLR6, MyD88, and Mal, but not TLR4, TRIF, or TRAM. J Immunol 2007, 178:1068.
69. Turner JD, Langley RS, Johnston KL, et al. Wolbachia lipoprotein stimulates innate and adaptive immunity through Toll-like receptors 2 and 6 (TLR2/6) to induce disease manifestations of filariasis. J Biol Chem 2009, 284:22364.
70. Babu S, Nutman TB Proinflammatory cytokines dominate the early immune response to filarial parasites. J Immunol 2003, 171:6723.
71. Graham SP, Trees AJ, Collins RA, et al. Down-regulated lymphoproliferation coincides with parasite maturation and with the collapse of both gamma interferon and interleukin-4 responses in a bovine model of onchocerciasis. Infect Immun 2001, 69:4313.
72. Taubert A, Zahner H Cellular immune responses of filaria (Litomosoides sigmodontis) infected BALB/c mice detected on the level of cytokine transcription. Parasite Immunol 2001, 23:453.
73. Schreuer D, Hammerberg B Modulation of cellular and humoral immunity, and disease manifestation during onset of patency in Brugia pahangi-infected dogs. Immunology 1993, 79:658.
74. Soboslay PT, Dreweck CM, Taylor HR, et al. Experimental onchocerciasis in chimpanzees. Cell-mediated immune responses, and production and effects of IL-1 and IL-2 with Onchocerca volvulus infection. J Immunol 1991, 147:346.
75. Nutman TB, Kumaraswami V Regulation of the immune response in lymphatic filariasis: perspectives on acute and chronic infection with Wuchereria bancrofti in South India. Parasite Immunol 2001, 23:389.
76. Bosshardt SC, Coleman SU, McVay CS, et al. Impact of microfilaremia on maintenance of a hyporesponsive cellular immune response in Brugia-infected gerbils (Meriones unguiculatus). Infect Immun 1995, 63:940.
77. Misra S, Mukherjee M, Dikshit M, et al. Cellular immune response of Mastomys and gerbils in experimental filariasis. Trop Med Int Health 1998, 3:124.
78. Rao UR, Nasarre C, Coleman SU, et al. Cellular immune responses of jirds to extracts of life cycle stages and adult excretory secretory products during the early development of Brugia pahangi. Exp Parasitol 1996, 82:255.
79. King CL, Mahanty S, Kumaraswami V, et al. Cytokine control of parasite-specific anergy in human lymphatic filariasis. Preferential induction of a regulatory T helper type 2 lymphocyte subset. J Clin Invest 1993, 92:1667.
80. Mahanty S, Mollis SN, Ravichandran M, et al. High levels of spontaneous and parasite antigen-driven interleukin-10 production are associated with antigen-specific hyporesponsiveness in human lymphatic filariasis. J Infect Dis 1996, 173:769.
81. Mahanty S, Ravichandran M, Raman U, et al. Regulation of parasite antigen-driven immune responses by interleukin-10 (IL-10) and IL-12 in lymphatic filariasis. Infect Immun 1997, 65:1742.
82. Ravichandran M, Mahanty S, Kumaraswami V, et al. Elevated IL-10 mRNA expression and downregulation of Th1-type cytokines in microfilaraemic individuals with Wuchereria bancrofti infection. Parasite Immunol 1997, 19:69.
83. Metenou S, Dembele B, Konate S, et al. Patent filarial infection modulates malaria-specific type 1 cytokine responses in an IL-10-dependent manner in a filaria/malaria-coinfected population. J Immunol 2009, 183:916.
84. Babu S, Kumaraswami V, Nutman TB Alternatively activated and immunoregulatory monocytes in human filarial infections. J Infect Dis 2009, 199:1827.
85. Maizels RM, Pearce EJ, Artis D, et al. Regulation of pathogenesis and immunity in helminth infections. J Exp Med 2009, 206:2059.
86. Ravindran B, Satapathy AK, Sahoo PK, et al. Protective immunity in human lymphatic filariasis: problems and prospects. Med Microbiol Immunol (Berl) 2003, 192:41.
87. Steel C, Guinea A, Ottesen EA Evidence for protective immunity to bancroftian filariasis in the Cook Islands. J Infect Dis 1996, 174:598.
88. Freedman DO, Nutman TB, Ottesen EA Protective immunity in bancroftian filariasis. Selective recognition of a 43-kD larval stage antigen by infection-free individuals in an endemic area. J Clin Invest 1989, 83:14.
89. Yates JA, Higashi GI Brugia malayi: vaccination of jirds with 60cobalt-attenuated infective stage larvae protects against homologous challenge. Am J Trop Med Hyg 1985, 34:1132.
90. Oothuman P, Denham DA, McGreevy PB, et al. Successful vaccination of cats against Brugia pahangi with larvae attenuated by irradiation with 10 krad cobalt 60. Parasite Immunol 1979, 1:209.
91. Storey DM, Al-Mukhtar AS Vaccination of jirds, Meriones unguiculatus, against Litomosoides carinii and Brugia pahangi using irradiate larvae of L. carinii. Tropenmed Parasitol 1982, 33:23.
92. Crandall R, Crandall C, Nayar J, et al. Resistance and disease in Brugia malayi infection of ferrets following prior infection, injection of attenuated infective larvae and injections of larval extracts. Parasite Immunol 1994, 16:425.
93. Gregory WF, Atmadja AK, Allen JE, et al. The abundant larval transcript-1 and -2 genes of Brugia malayi encode stage-specific candidate vaccine antigens for filariasis. Infect Immun 2000, 68:4174.
94. Vedi S, Dangi A, Hajela K, et al. Vaccination with 73kDa recombinant heavy chain myosin generates high level of protection against Brugia malayi challenge in jird and mastomys models. Vaccine 2008, 26:5997.
95. Vanam U, Pandey V, Prabhu PR, et al. Evaluation of immunoprophylactic efficacy of Brugia malayi transglutaminase (BmTGA) in single and multiple antigen vaccination with BmALT-2 and BmTPX for human lymphatic filariasis. Am J Trop Med Hyg 2009, 80:319.
96. Vanam U, Prabhu PR, Pandey V, et al. Immune responses generated by intramuscular DNA immunization of Brugia malayi transglutaminase (BmTGA) in mice. Parasitology 2009, 136:887.
97. Veerapathran A, Dakshinamoorthy G, Gnanasekar M, et al. Evaluation of Wuchereria bancrofti GST as a vaccine candidate for lymphatic filariasis. PLoS Negl Trop Dis 2009, 3:e457.
98. Dreyer G, Santos A, Noroes J, et al. Amicrofilaraemic carriers of adult Wuchereria bancrofti. Trans R Soc Trop Med Hyg 1996, 90:288.
99. Dreyer G, Noroes J, Rocha A, et al. Detection of living adult Wuchereria bancrofti in a patient with tropical pulmonary eosinophilia. Braz J Med Biol Res 1996, 29:1005.
100. Dreyer G, Brandao AC, Amaral F, et al. Detection by ultrasound of living adult Wuchereria bancrofti in the female breast. Mem Inst Oswaldo Cruz 1996, 91:95.
101. Dreyer G, Santos A, Noroes J, et al. Ultrasonographic detection of living adult Wuchereria bancrofti using a 3.5-MHz transducer. Am J Trop Med Hyg 1998, 59:399.
102. Eberhard ML, Lammie PJ Laboratory diagnosis of filariasis. Clin Lab Med 1991, 11:977.
103. More SJ, Copeman DB A highly specific and sensitive monoclonal antibody-based ELISA for the detection of circulating antigen in bancroftian filariasis. Trop Med Parasitol 1990, 41:403.
104. Weil GJ, Lammie PJ, Weiss N The ICT Filariasis Test: a rapid-format antigen test for diagnosis of bancroftian filariasis. Parasitol Today 1997, 13:401.
105. Lizotte MR, Supali T, Partono F, et al. A polymerase chain reaction assay for the detection of Brugia malayi in blood. Am J Trop Med Hyg 1994, 51:314.
106. Rao UR, Williams SA, Klei TR Quantification of PCR amplification products of Brugia HhaI repeat DNA using a semiautomated Q-PCR system. Mol Cell Probes 2002, 16:13.
107. Kluber S, Supali T, Williams SA, et al. Rapid PCR-based detection of Brugia malayi DNA from blood spots by DNA detection test strips. Trans R Soc Trop Med Hyg 2001, 95:169.
108. Rahmah N, Ashikin AN, Anuar AK, et al. PCR-ELISA for the detection of Brugia malayi infection using finger-prick blood. Trans R Soc Trop Med Hyg 1998, 92:404.
109. McCarthy JS, Zhong M, Gopinath R, et al. Evaluation of a polymerase chain reaction-based assay for diagnosis of Wuchereria bancrofti infection. J Infect Dis 1996, 173:1510.
110. Nutman TB, Zimmerman PA, Kubofcik J, et al. A universally applicable diagnostic approach to filarial and other infections. Parasitol Today 1994, 10:239.
111. Lal RB, Ottesen EA Enhanced diagnostic specificity in human filariasis by IgG4 antibody assessment. J Infect Dis 1988, 158:1034.
112. Lammie PJ, Weil G, Rahmah N, et al. Recombinant antigen-based antibody assays for the diagnosis and surveillance of lymphatic filariasis - a multicenter trial. Filaria J 2004, 3:9.
113. Rahmah N, Taniawati S, Shenoy RK, et al. Specificity and sensitivity of a rapid dipstick test (Brugia Rapid) in the detection of Brugia malayi infection. Trans R Soc Trop Med Hyg 2001, 95:601.
114. El Setouhy M, Ramzy RM, Ahmed ES, et al. A randomized clinical trial comparing single- and multi-dose combination therapy with diethylcarbamazine and albendazole for treatment of bancroftian filariasis. Am J Trop Med Hyg 2004, 70:191.
115. Horton J, Witt C, Ottesen EA, et al. An analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis. Parasitology 2000, 121(suppl):S147.
116. Molyneux DH, Bradley M, Hoerauf A, et al. Mass drug treatment for lymphatic filariasis and onchocerciasis. Trends Parasitol 2003, 19:516.
117. Ottesen EA Major progress toward eliminating lymphatic filariasis. N Engl J Med 2002, 347:1885.
118. Addiss D, Critchley J, Ejere H, et al. Albendazole for lymphatic filariasis. Cochrane Database Syst Rev. 2004:CD003753.
119. Jamal S Lymphovenous anastomosis in filarial lymphedema. Lymphology 1981, 14:64.
120. Ottesen EA, Duke BO, Karam M, et al. Strategies and tools for the control/elimination of lymphatic filariasis. Bull WHO 1997, 75:491.
121. Molyneux DH, Zagaria N Lymphatic filariasis elimination: progress in global programme development. Ann Trop Med Parasitol 2002, 96(suppl 2):S15.
122. Ottesen EA, Hooper PJ, Bradley M, et al. The global programme to eliminate lymphatic filariasis: health impact after 8 years. PLoS Negl Trop Dis 2008, 2:e317.
123. Bockarie MJ, Molyneux DH The end of lymphatic filariasis?. BMJ 2009, 338:b1686.
124. Molyneux D Lymphatic filariasis (elephantiasis) elimination: a public health success and development opportunity. Filaria J 2003, 2:13.
125. Global programme to eliminate lymphatic filariasis. Wkly Epidemiol Rec 2009, 84:437.
126. Brady MA, Hooper PJ, Ottesen EA Projected benefits from integrating NTD programs in sub-Saharan Africa. Trends Parasitol 2006, 22:285.
127. Smits HL Prospects for the control of neglected tropical diseases by mass drug administration. Expert Rev Anti Infect Ther 2009, 7:37.
128. Blackburn BG, Eigege A, Gotau H, et al. Successful integration of insecticide-treated bed net distribution with mass drug administration in Central Nigeria. Am J Trop Med Hyg 2006, 75:650.
129. Richards FO, Eigege A, Miri ES, et al. Integration of mass drug administration programmes in Nigeria: the challenge of schistosomiasis. Bull WHO 2006, 84:673.
130. Haddad D, Cross C, Thylefors B, et al. Health care at the end of the road: opportunities from 20 years of partnership in onchocerciasis control. Glob Public Health 2008, 3:187.
131. Tadesse Z, Hailemariam A, Kolaczinski JH Potential for integrated control of neglected tropical diseases in Ethiopia. Trans R Soc Trop Med Hyg 2008, 102:213.
132. Matthews GA, Dobson HM, Nkot PB, et al. Preliminary examination of integrated vector management in a tropical rainforest area of Cameroon. Trans R Soc Trop Med Hyg 2009.